BLOCKADE OF ACQUISITION OF DRUG-CONDITIONED PLACE AVERSION BY 5HT3 ANTAGONISTS

被引:35
作者
ACQUAS, E [1 ]
CARBONI, E [1 ]
GARAU, L [1 ]
DICHIARA, G [1 ]
机构
[1] UNIV CAGLIARI, INST EXPTL PHARMACOL & TOXICOL, VIALE A DIAZ 182, I-09126 CAGLIARI, ITALY
关键词
5-HT; 5HT[!sub]3[!/sub] antagonist; Naloxone; Phencyclidine; Picrotoxin;
D O I
10.1007/BF02243996
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The effect of two 5HT3 antagonists, ICS 205-930 and MDL 72222, on drug-induced place aversion was studied in a two-compartment apparatus with a procedure including a pre-test for spontaneous preference. Naloxone (0.8 mg/kg SC), phencyclidine (2.5 mg/kg SC) and picrotoxin (2.0 mg/kg IP) paired with the preferred compartment elicited a significant place aversion. ICS 205-930 and MDL 72222 failed to modify spontaneous place preference when paired with both compartments. ICS 205-930 (30 μg/kg SC) paired with the preferred and, in other experiments, with the non-preferred compartment, also failed to modify spontaneous preference. ICS 205-930 (7.5, 15 and 30 μg/kg SC), paired with both compartments, dose-dependently reduced the place aversion induced by naloxone (0.8 mg/kg SC), phencyclidine (2.5 mg/kg SC) and picrotoxin (2.0 mg/kg IP). MDL 72222 (30 μg/kg SC) paired with both compartments had a similar effect. The result indicate that 5HT, via 5HT3 receptors, plays a role in the aversive properties of drug stimuli. © 1990 Springer-Verlag.
引用
收藏
页码:459 / 463
页数:5
相关论文
共 14 条
[1]   PROPOSALS FOR THE CLASSIFICATION AND NOMENCLATURE OF FUNCTIONAL RECEPTORS FOR 5-HYDROXYTRYPTAMINE [J].
BRADLEY, PB ;
ENGEL, G ;
FENIUK, W ;
FOZARD, JR ;
HUMPHREY, PPA ;
MIDDLEMISS, DN ;
MYLECHARANE, EJ ;
RICHARDSON, BP ;
SAXENA, PR .
NEUROPHARMACOLOGY, 1986, 25 (06) :563-576
[2]   5HT3 RECEPTOR ANTAGONISTS BLOCK MORPHINE-INDUCED AND NICOTINE-INDUCED BUT NOT AMPHETAMINE-INDUCED REWARD [J].
CARBONI, E ;
ACQUAS, E ;
LEONE, P ;
DICHIARA, G .
PSYCHOPHARMACOLOGY, 1989, 97 (02) :175-178
[3]   DIFFERENTIAL INHIBITORY EFFECTS OF A 5-HT3 ANTAGONIST ON DRUG-INDUCED STIMULATION OF DOPAMINE RELEASE [J].
CARBONI, E ;
ACQUAS, E ;
FRAU, R ;
DICHIARA, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 164 (03) :515-519
[4]   ANIMAL-MODELS OF ANXIETY - THE EFFECT OF COMPOUNDS THAT MODIFY 5-HT NEUROTRANSMISSION [J].
CHOPIN, P ;
BRILEY, M .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1987, 8 (10) :383-388
[5]   NEUROANATOMICAL SITES OF ACTION OF 5-HT3 RECEPTOR AGONIST AND ANTAGONISTS FOR ALTERATION OF AVERSIVE BEHAVIOR IN THE MOUSE [J].
COSTALL, B ;
KELLY, ME ;
NAYLOR, RJ ;
ONAIVI, ES ;
TYERS, MB .
BRITISH JOURNAL OF PHARMACOLOGY, 1989, 96 (02) :325-332
[6]   A 5-HT RECEPTOR IN THE CENTRAL NERVOUS-SYSTEM, POSITIVELY COUPLED WITH ADENYLATE-CYCLASE, IS ANTAGONIZED BY ICS-205-930 [J].
DUMUIS, A ;
BOUHELAL, R ;
SEBBEN, M ;
BOCKAERT, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 146 (01) :187-188
[8]  
IWAMOTO E T, 1986, Alcohol and Drug Research, V6, P265
[9]  
JONES B J, 1987, British Journal of Pharmacology, V90, p88P
[10]   THE POTENTIAL ANXIOLYTIC ACTIVITY OF GR38032F, A 5-HT3-RECEPTOR ANTAGONIST [J].
JONES, BJ ;
COSTALL, B ;
DOMENEY, AM ;
KELLY, ME ;
NAYLOR, RJ ;
OAKLEY, NR ;
TYERS, MB .
BRITISH JOURNAL OF PHARMACOLOGY, 1988, 93 (04) :985-993